KRYS R&D to Revenue
Krystal Biotech Inc · R&D to Revenue
KRYS R&D to Revenue
Latest reported12.18%period ending
KRYS Quarterly R&D/Revenue (0.00% → 12.18%)
Latest values, visible window
High-resolution chart · PNG
KRYS r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 12.1773% | |
| 13.1758% | |
| 15.1207% | |
| 13.4816% | |
| 15.0039% | |
| 16.1652% | |
| 14.8378% | |
| 16.115% | |
| 22.1715% | |
| 24.2144% | |
| 26.9796% | |
| 124.2286% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 777.8598% | |
| 543.2247% | |
| 272.8335% | |
| 882.0276% | |
| 881.5029% | |
| 1,196.8504% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |